Pterolactone A shows potential in anti-inflammatory and anticancer applications. It has demonstrated inhibitory effects on certain cancer cell lines by inducing apoptosis and suppressing cell proliferation. Studies suggest it may interfere with signaling pathways involved in tumor growth and inflammation, such as NF-κB and MAPK pathways. Due to its bioactive properties, Pterolactone A is being explored as a lead compound for developing natural product-based therapeutics, particularly in oncology and chronic inflammatory conditions. Its presence in specific plant sources also makes it a candidate for phytochemical research aimed at drug discovery.